COVID-19 Vaccine Trial Volunteer in India Develops Encephalopathy and Sues

COVID-19 Vaccine Trial Volunteer in India Develops Encephalopathy and Sues

A 40-year old business consultant in India, who volunteered to be a participant in clinical trials of the experimental COVID-19 vaccine (Covishield) created by AstraZeneca and Oxford University is suing Serum Institute of India (SII), which is producing the vaccine in India, for 50 million rupees ($680,000) after he developed acute encephalopathy (brain dysfunction) within […]

Brazilian Doctor Dies Participating in AstraZeneca’s COVID-19 Vaccine Clinical Trial

Brazilian Doctor Dies Participating in AstraZeneca’s COVID-19 Vaccine Clinical Trial

Story Highlights A COVID-19 vaccine trial participant, who was a physician working with COVID-19 patients at hospitals in Brazil, has reportedly died from coronavirus infection complications. It has not been confirmed, but sources indicate the victim was given the trial “placebo” (a meningococcal vaccine) and not the experimental AZD1222 vaccine developed by pharmaceutical company AstraZeneca […]

Pfizer Wants to Use Children in COVID-19 Vaccine Clinical Trial

Pfizer Wants to Use Children in COVID-19 Vaccine Clinical Trial

On Oct. 14, 2020, Pfizer, Inc. of New York City, New York announced it had received approval by the U.S. Food and Drug Administration (FDA) to enroll children in the Phase 3 human clinical trial on its experimental messenger RNA (ribonucleic acid) BNT162b1 vaccine for COVID-19. The trial, which last month was expanded to include adolescent […]

How Will Unhealthy Americans React to COVID-19 Vaccines?

How Will Unhealthy Americans React to COVID-19 Vaccines?

If you look at the human clinical trials that have been conducted this year by drug companies developing experimental vaccines for COVID-19, the participants in those trials have all been “healthy adults.” Take, for example, Moderna’s Phase 1 clinical trial for its mRNA-1273 vaccine, which included 45 healthy adults 18 to 55 years old. The same […]

AstraZeneca Halts, Resumes COVID-19 Vaccine Trial After Serious Neurological Event

AstraZeneca Halts, Resumes COVID-19 Vaccine Trial After Serious Neurological Event

News update, Sept. 15, 2020—U.S. regulators paused AstraZeneca’s vaccine trial in the U.S. while the National Institutes of Health (NIH) launches an investigation of its own into a serious side effect in an unnamed patient in Britain. “The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader […]